Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

BUY
$10.6 - $13.28 $153,265 - $192,015
14,459 New
14,459 $172,000
Q4 2021

Feb 14, 2022

SELL
$10.21 - $15.27 $112,003 - $167,511
-10,970 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$14.07 - $17.3 $9,863 - $12,127
701 Added 6.83%
10,970 $160,000
Q2 2021

Aug 16, 2021

BUY
$16.62 - $18.94 $25,877 - $29,489
1,557 Added 17.87%
10,269 $178,000
Q1 2021

May 14, 2021

SELL
$15.15 - $19.78 $1,363 - $1,780
-90 Reduced 1.02%
8,712 $151,000
Q4 2020

Feb 10, 2021

BUY
$16.86 - $19.67 $9,829 - $11,467
583 Added 7.09%
8,802 $162,000
Q3 2020

Nov 13, 2020

SELL
$15.4 - $20.16 $473,919 - $620,403
-30,774 Reduced 78.92%
8,219 $143,000
Q2 2020

Aug 11, 2020

BUY
$18.24 - $21.45 $163,102 - $191,805
8,942 Added 29.76%
38,993 $711,000
Q1 2020

May 12, 2020

SELL
$16.28 - $25.63 $61,229 - $96,394
-3,761 Reduced 11.12%
30,051 $605,000
Q4 2019

Feb 11, 2020

BUY
$19.57 - $23.52 $480,443 - $577,416
24,550 Added 265.06%
33,812 $787,000
Q3 2019

Nov 13, 2019

BUY
$19.85 - $22.76 $57,545 - $65,981
2,899 Added 45.56%
9,262 $186,000
Q2 2019

Aug 14, 2019

BUY
$17.59 - $21.1 $91,714 - $110,015
5,214 Added 453.79%
6,363 $134,000
Q1 2019

May 14, 2019

SELL
$18.01 - $20.11 $90 - $100
-5 Reduced 0.43%
1,149 $23,000
Q4 2018

Feb 13, 2019

SELL
$17.44 - $21.53 $4,743 - $5,856
-272 Reduced 19.07%
1,154 $21,000
Q1 2018

May 16, 2018

SELL
$20.31 - $24.95 $46,022 - $56,536
-2,266 Reduced 61.38%
1,426 $30,000
Q4 2017

Feb 13, 2018

BUY
$20.99 - $23.89 $1,847 - $2,102
88 Added 2.44%
3,692 $85,000
Q3 2017

Nov 08, 2017

BUY
$20.07 - $21.89 $8,208 - $8,953
409 Added 12.8%
3,604 $79,000
Q2 2017

Aug 15, 2017

SELL
N/A
-402 Reduced 11.18%
3,195 $68,000
Q1 2017

Sep 15, 2017

SELL
N/A
-33 Reduced 0.91%
3,597 $68,000
Q4 2016

Sep 15, 2017

BUY
N/A
174 Added 5.03%
3,630 $58,000
Q3 2016

Sep 15, 2017

BUY
N/A
427 Added 14.1%
3,456 $55,000
Q2 2016

Sep 15, 2017

BUY
N/A
1,753 Added 137.38%
3,029 $50,000
Q1 2016

Sep 15, 2017

BUY
N/A
762 Added 148.25%
1,276 $20,000
Q4 2015

Sep 15, 2017

BUY
N/A
514
514 $8,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.57B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.